Bluejay signs federal distribution deal with Lovell for SDVOSB set-aside markets

Bluejay Diagnostics, Inc.

Exclusive SDVOSB set-aside distributor for VA, DoD, IHS procurements; non-exclusive rights on open-market federal/state/local deals.
One-time $5,500 establishment fee paid; Lovell earns ~15% distribution fee on gross federal catalog sales plus 2% for DAPA prime vendor sales.
Two-year initial term, auto-renewing annually unless 90-day notice; termination rights for default, bankruptcy, or $100K+ judgments.
Deal signed Sep 1, 2026; press release Sep 8, 2026; partnership precedes FDA clearance, Symphony still investigational.
Lovell provides access to VA FSS, GSA Advantage, MAS, ECAT, DAPA; co-marketing targets VHA ($165.1B FY2026 budget) and DoD/DHA ($64B).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.